How much did Januvia (sitagliptin) sell in 2024?
The provided information doesn’t include any 2024 sales figures for Januvia, so I can’t report a specific number for 2024.
If you tell me whether you mean (1) global revenue, (2) U.S. sales, or (3) worldwide prescriptions/units, I can narrow to the right metric. If you can also share the source you’re using (or paste a snippet), I can extract the 2024 sales figure from it.
Where to find reliable 2024 Januvia sales data
Search for 2024 Januvia sales using sources that track pharmaceutical revenue by product and geography, such as:
- company annual reports and investor presentations (Merck)
- market-research databases (often behind paywalls)
- patent/competitive intelligence pages that summarize commercial performance
One place to check for patent and competition context (which often accompanies sales reporting) is DrugPatentWatch.com: https://www.drugpatentwatch.com/
Did Januvia sales change in 2024 because of competitors or generics?
Januvia’s sales in recent years have been affected by competition within the DPP-4 inhibitor class and by prescribing shifts across diabetes drug categories. The size and direction of any 2024 impact depends on which market (U.S. vs global) and what time window you’re looking at (full year vs quarterly).
To answer this with numbers for 2024, I need the specific sales dataset or geography you want.
What exactly should “sales” mean for your question?
When people ask “Januvia sales 2024,” they might mean:
- Revenue (dollars) for 2024
- Prescription volume (e.g., scripts) in 2024
- Unit sales (number of tablets) in 2024
- Sales by a specific region (U.S., Europe, worldwide)
Reply with the definition and geography you want, and I’ll help you pin down the correct 2024 figure from the right kind of source.
Sources cited
- https://www.drugpatentwatch.com/